Novartis to buy 25% of Alcon

Article

Novartis is to purchase 25% of Alcon from majority stakeholder Nestlé, with an option to purchase Nestlé's remaining shares, which currently amount to approximately 52% of Alcon.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
Harvey Uy, MD, DPBO, FVRSP, speaks about artificial intelligence (AI) and optical coherence tomography (OCT) at the 2025 European Society of Retina Specialists (EURETINA) Congress.
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Related Content
An image of an iris placed over a digital interlay. Concept image for BVI Medical and VirtuaLens new technologies at European Society of Cataract and Refractive Surgeons meeting in Copenhagen, Denmark. (Image credit: ©spainter_vfx/AdobeStock)

BVI, VirtuaLens will showcase new technologies at ESCRS 2025

Kassi Filkins
September 12th 2025
Article
Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD
September 12th 2025
Podcast
The Intercil Uveal Spacer from Ciliatech, which recently obtained a CE mark, does not penetrate the anterior of the eye. All images courtesy of Ciliatech.

Ciliatech leadership comments on CE mark for novel glaucoma device

Hattie Hayes;Kassi Filkins
September 12th 2025
Article
A photo of Prithvi Ramtohul, MD, who received the Ramin Tadayoni Award at the 2025 EURETINA Congress.

EURETINA grants Prithvi Ramtohul, MD, 2025 Ramin Tadayoni Award

Hattie Hayes
September 12th 2025
Article
EMA grants Orphan designations to MCO-010 across 5 categories of retinal dystrophies

EMA grants Orphan designations to MCO-010 across 5 categories of retinal dystrophies

Sydney M Crago
September 12th 2025
Article
A movie theatre with empty seats. The screen has reels of film negatives, with a blue tint, and the words "Coming Soon" in large yellow letters. Image credit: Created with Canva. Components via Photology2000 and Ron Lach, Pexels.

EURETINA industry previews: Beacon Therapeutics, Nanoscope Therapeutics and Valitor

Kassi Filkins
September 12th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.